News & HighlightsNews
Study of “breakthrough” cases suggests COVID testing may be here to stay
Two new cases helped scientists confirm what many have come to suspect: that people can get infected by SARS-CoV-2 variants even after successful vaccination. The findings suggest continued testing may be needed to prevent future outbreaks in a post-vaccine world. <...
Inside the protein channel that keeps bacteria alive
A novel method for studying how one crucial membrane protein functions may pave the way for a new kind of broad-spectrum antibiotic.
Brain disease transmitted by tick bites may be treatable
The virus that causes tick-borne encephalitis appears to trick the immune system, misdirecting it into producing inferior antibodies. But new research shows some people produce more potent antibodies, providing hope for treatment.
How one patient’s rare mutation helped solve a mycobacterial mystery
The discovery may explain why some patients suffer more severe reactions than others—putting us one step closer to understanding how our DNA influences our susceptibility to a wide range of infectious diseases.
Financial crashes, pandemics, Texas snow: How math could predict "black swan" events
Statistical modeling may one day help scientists anticipate and manage a wide range of extreme occurrences, according to a new study.
An old antibiotic may combat drug-resistant tuberculosis
Drug-resistant strains of tuberculosis bacteria affect half a million people a year. A compound first discovered in the 1980s may be able to help.
Why male mosquitoes leave humans alone
Unlike their female counterparts, male mosquitoes have no desire to bite us. But the hardware for host-seeking is hidden in the male mosquito brain, locked behind a simple genetic switch. 
Rockefeller grants commercial license for the development of monoclonal antibodies for treatment of COVID-19
The treatment, a combination of two antibodies, has been shown highly capable of neutralizing SARS-CoV-2 in preclinical studies. Researchers hope it will give countries around the world, including developing countries, a way to control the rampant disease.
COVID-19 vaccines may need regular updates for emerging variants
Lab experiments suggest that the new strains reported in Britain, South Africa, and Brazil may blunt the potency of the Pfizer and Moderna COVID-19 vaccines. This could mean that the vaccines will need updates as the virus mutates.
Synthetic “micro lungs” could take COVID-19 research to the next level
Scientists have developed stem-cell technology to mass-produce tissue cultures resembling our breathing organs. These tissues offer a powerful model in which to study how SARS-CoV-2 wreaks havoc in the lungs and to screen for new drugs.
View
View